Is there a connection between flushing toilets and patient safety? 🚽🔒 Surprisingly, the answer is yes. In a recent podcast with Indy, I delve into this unexpected relationship. Because these days that's what the cool kids do, no?
On a serious note, the conversation was so engaging that I was genuinely disappointed when it concluded. If you can relate to any of the discussion points, reach out - we should probably be friends.
#PatientSafety#Pharmacovigilance
🚀 Exciting News! Our next podcast episode drops this Monday, and you won't want to miss it! 🎙️
What happens when a background in neurobiology intersects with a serendipitous dive into pharmacovigilance? 🌐 Join us as Sibel Guerler, Head of Strategy and Safety Evolution at BMS, shares her incredible journey from managing databases to pioneering cutting-edge technologies in drug safety.
Tune in to explore how pivotal FDA and EMA legislations have shaped the last two decades, and why modern, agile safety approaches are crucial today. Discover the strategic role of safety teams in the competitive world of drug development and how Sibel’s passion and adaptability turned a career into a true calling. 🔍
Prepare to be inspired and empowered. 🚀✨
Subscribe so you don't miss out! You can listen to the previous seasons of our “Innovation and the Future of Pharmacovigilance” podcasts from any of these platforms;
🍏 Apple: https://lnkd.in/epCStTmJ
🎧 Spotify: https://lnkd.in/esHKmjvT
📺 YouTube Podcasts: https://lnkd.in/esZKjJig
📣 TuneIn + Alexa: https://lnkd.in/eQEJsUch
🔊 Amazon Music: https://lnkd.in/eNWGUQmY
🌐 Podcast Index: https://lnkd.in/enPKXcNW
💾 Deezer: https://lnkd.in/epFDaMV5
🎤 Player FM: https://lnkd.in/ePcgvTFz#Pharmacovigilance#RiskManagement#TruliantConsulting
🎙️ GLOBAL CROs OR NICHE SPECIALISTS? 🌐 Let's Talk Clinical Research Partnerships!
🤝 Don't miss Season 2, Episode 4 of the Clinical Data Management Best Practices podcast!
🎧 Join Institute of Biostatistics and Analyses podcast team as they chat with our amazing guests, Lucie Špatenková and Radek Špatenka from the Clinical Research Center, a company responsible for shaking up drug development and testing in the Czech Republic and Slovakia.
Here's what we've got for you:
💡 Discover how CRC's strategy is changing the game in clinical research.
💡 Get the scoop on handling decentralized trials as Clinical Research Associates (CRAs).
💡 Find out how to pick the right partners for your clinical trials: big CROs or niche specialists?
Interesting?
Catch this episode on Apple Podcasts and Spotify. Links are in the comments below. Drop a comment to let us know what you think!
In this episode, Benjamin Malcolm, PharmD, MPH (AKA the Spirit Pharmacist) brings us into the intersection of psychedelics and pharmacology. This episode is full of practical considerations for tapering off SSRIs before embarking on a psychedelic experience and navigating contraindications between psychedelics and antidepressants.
Throughout the conversation, Ben offers valuable insights into crafting tapering protocols:
Topics Covered:
💊 How psychedelics fit into pharmaceuticals
💊 Guidelines from tapering off of SSRIs before a psychedelic experience
💊 Psychedelics that are compatible or not with anti-depressants
💊 What to consider when embarking on a tapering protocol
💊 #Microdosing and tapering
💊 The risk of valvular heart disease with psilocybin mushrooms
💊Drug interactions with psychedelics to be aware of
💊Reintroducing substances/alcohol after #Iboga / #Ibogaine
💊The mystery of #5MeODMT reactivations and #Cannabis
LISTEN NOW:
Apple: https://lnkd.in/g3Q3p9ze
Spotify: https://lnkd.in/gf26w3_C
YouTube: https://lnkd.in/gZH5gJtD#Psychedelics#PsychedelicScience#PsychedelicResearch#PsychedelicPharmacology
